Authors: Vaarala, MH Porvari, KS Kellokumpu, S Kyllonen, AP Vihko, PT

Citation: Mh. Vaarala et al., Expression of transmembrane serine protease TMPRSS2 in mouse and human tissues, J PATHOLOGY, 193(1), 2001, pp. 134-140

Authors: Vaaraka, MH Lukkarinen, O Marttila, T Kyllonen, AP Porvari, KS Vihko, PT

Citation: Mh. Vaaraka et al., Prostatic expression of human 5 alpha-reductase type 2 during finasteride therapy: a randomized, double-blind, placebo-controlled study, WORLD J URO, 18(6), 2000, pp. 406-410

Authors: Niemi, M Kervinen, K Kiviniemi, H Lukkarinen, O Kyllonen, AP Apaja-Sarkkinen, M Savolainen, MJ Kairaluoma, MI Kesaniemi, YA

Citation: M. Niemi et al., Apolipoprotein E phenotype, cholesterol and breast and prostate cancer, J EPIDEM C, 54(12), 2000, pp. 938-939

Authors: Raatikainen, TK Kaarela, OI Holmstrom, T Kyllonen, AP Teerikangas, HE Waris, TH

Citation: Tk. Raatikainen et al., Desmoplastic fibroma of the calcaneus treated with a microvascular bone graft - Case report, SC J PLAST, 33(1), 1999, pp. 111-116

Authors: Elo, JP Harkonen, P Kyllonen, AP Lukkarinen, O Vihko, P

Citation: Jp. Elo et al., Three independently deleted regions at chromosome arm 16q in human prostate cancer: allelic loss at 16q24.1-q24.2 is associated with aggressive behaviour of the disease, recurrent growth, poor differentiation of the tumour and poor prognosis for the patient, BR J CANC, 79(1), 1999, pp. 156-160